Current research suggests that adiponectin exerts its effect by binding to its receptors and regulating AKT/mTOR/PI3K and MAPK signaling pathways, which are associated with cell proliferation and energy modulation, thereby inhibiting the activity and growth of thyroid cancer (16). This evidence concerns the gene AKT1 and thyroid cancer.